Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sulforaphane inhibits NLRP3 inflammasome activation in microglia through Nrf2-mediated miRNA alteration
Kemal Uğur Tüfekçi, İlkcan Ercan, Kamer Burak Isci, et al.
Immunology Letters (2021) Vol. 233, pp. 20-30
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

The Role of NLRP3 Inflammasome in Alzheimer’s Disease and Potential Therapeutic Targets
Tao Liang, Yang Zhang, Suyuan Wu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 115
Understanding the involvement of innate immunity and the Nrf2-NLRP3 axis on mitochondrial health in Parkinson's disease
Shruti Rajan, Kamatham Pushpa Tryphena, Sabiya Samim Khan, et al.
Ageing Research Reviews (2023) Vol. 87, pp. 101915-101915
Closed Access | Times Cited: 40
Resveratrol Inhibits NLRP3 Inflammasome-Induced Pyroptosis and miR-155 Expression in Microglia Through Sirt1/AMPK Pathway
Kemal Uğur Tüfekçi, Bedir Irem Eltutan, Kamer Burak Isci, et al.
Neurotoxicity Research (2021) Vol. 39, Iss. 6, pp. 1812-1829
Closed Access | Times Cited: 54
Targeting NLRP3 Inflammasome With Nrf2 Inducers in Central Nervous System Disorders
Bora Tastan, Burak I. Ariöz, Şermin Genç
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 41
Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Alzheimer’s disease
Nourhan M. Abdelmaksoud, Al-Aliaa M. Sallam, Ahmed I. Abulsoud, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 155007-155007
Closed Access | Times Cited: 22
Bioactive sulforaphane from cruciferous vegetables: advances in biosynthesis, metabolism, bioavailability, delivery, health benefits, and applications
Yanli Zhang, Wenyuan Zhang, Yaqi Zhao, et al.
Critical Reviews in Food Science and Nutrition (2024), pp. 1-21
Closed Access | Times Cited: 7
Microglia Pyroptosis: A Candidate Target for Neurological Diseases Treatment
Xian Wu, Teng Wan, Xiaoyu Gao, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 28
Exploring the anti‐inflammatory activity of sulforaphane
Katie Treasure, James Harris, Gary Williamson
Immunology and Cell Biology (2023) Vol. 101, Iss. 9, pp. 805-828
Open Access | Times Cited: 20
Exosomes and non-coding RNAs: bridging the gap in Alzheimer’s pathogenesis and therapeutics
Chunhui Guo, You Yanqiu, Jibing Chen, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 1
Open Access
Research Progress in the Molecular Mechanism of NLRP3 Inflammasome in Alzheimer’s Disease and Regulation by Natural Plant Products
Runru Zu, Lu Hao, Wanting Liu, et al.
Molecular Neurobiology (2025)
Closed Access
Sulforaphane: An emerging star in neuroprotection and neurological disease prevention
Na Wu, Zhongping Luo, Rui Deng, et al.
Biochemical Pharmacology (2025) Vol. 233, pp. 116797-116797
Closed Access
Pyroptosis; igniting neuropsychiatric disorders from mild depression to aging-related neurodegeneration
Kiavsh Hushmandi, Rüssel J. Reiter, Najma Farahani, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111325-111325
Closed Access
Inhibitory effects of sulforaphane on NLRP3 inflammasome activation
Cagla Kiser, Ceren Perihan Gonul, Melis Olcum, et al.
Molecular Immunology (2021) Vol. 140, pp. 175-185
Closed Access | Times Cited: 34
NRF2 Activation and Downstream Effects: Focus on Parkinson’s Disease and Brain Angiotensin
Juan A. Parga, Ana I. Rodríguez‐Pérez, María García-Garrote, et al.
Antioxidants (2021) Vol. 10, Iss. 11, pp. 1649-1649
Open Access | Times Cited: 32
NLRP3 Inflammasome: From Pathophysiology to Therapeutic Target in Major Depressive Disorder
Bruna R. Kouba, Joana Gil‐Mohapel, Ana Lúcia S. Rodrigues
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 133-133
Open Access | Times Cited: 26
The Role of the NLRP3 Inflammasome in Mediating Glomerular and Tubular Injury in Diabetic Nephropathy
Bethany M. Williams, Chelsy L. Cliff, K. Lee, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 23
Nrf2 Signaling in the Oxidative Stress Response After Spinal Cord Injury
Xudong Guo, Jihe Kang, Zhaoheng Wang, et al.
Neuroscience (2022) Vol. 498, pp. 311-324
Closed Access | Times Cited: 22
Non-Coding RNA in Microglia Activation and Neuroinflammation in Alzheimer’s Disease
Chunxiang He, Ze Li, Miao Yang, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 4165-4211
Open Access | Times Cited: 13
Glucose metabolite methylglyoxal induces vascular endothelial cell pyroptosis via NLRP3 inflammasome activation and oxidative stress in vitro and in vivo
Yanan Wang, Jinxiang Chen, Youkun Zheng, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 4
NRF2 as a therapeutic opportunity to impact in the molecular roadmap of ALS
José Jiménez-Villegas, Laura Ferraiuolo, Richard J. Mead, et al.
Free Radical Biology and Medicine (2021) Vol. 173, pp. 125-141
Open Access | Times Cited: 31
β2-adrenoceptor agonist formoterol attenuates NLRP3 inflammasome activation and GSDMD-mediated pyroptosis in microglia through enhancing IκBα/NF-κB inhibition, SQSTM1/p62-dependent selective autophagy and ESCRT-III-mediated plasma membrane repair
Mehmet Erdem, Şeniz Erdem, Ahmet Alver, et al.
Molecular and Cellular Neuroscience (2024) Vol. 130, pp. 103956-103956
Closed Access | Times Cited: 3
Epigallocatechin-3-Gallate Inhibits Oxidative Stress Through the Keap1/Nrf2 Signaling Pathway to Improve Alzheimer Disease
Shi Tang, Yong Zhang, Benson O. A. Botchway, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 3
Redox Regulation of Nucleotide-Binding and Oligomerization Domain-Like Receptors Inflammasome
Francesca Ferrara, Alessandra Pecorelli, Giuseppe Valacchi
Antioxidants and Redox Signaling (2023) Vol. 39, Iss. 10-12, pp. 744-770
Closed Access | Times Cited: 8
MicroRNAs Modulating Neuroinflammation in Parkinson's disease
Mohamed J. Saadh, Faris Anad Muhammad, Anamika Singh, et al.
Inflammation (2024)
Closed Access | Times Cited: 2
Sulforaphane Modulates the Inflammation and Delays Neurodegeneration on a Retinitis Pigmentosa Mice Model
Antolín Cantó, Javier Martínez, María Miranda, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top